Jump to navigation
Despite recent advances, there's still a need to make noise about "the silent disease."
The public sector has a key role in drug R&D. Patenting minor changes to extend monopoly prices spells misuse By Dr. Brian Druker
By Dr. Tido von Schoen-Angerer Executive director Access to Essential Medicines Campaign Doctors Without Borders
Dr. Buddhima Lokuge U.S. manager, Access to Essential Medicines Campaign
By David Wilson Medical Coordinator, Doctors Without Borders/Médecins Sans Frontieres
By Dr. Richard Rockefeller Chairman, Doctors Without Borders/Médecins Sans Frontières (MSF) Board of Advisors
By Dr. Jean-Hervé Bradol President, Médecins Sans Frontières
By Rowan Gillies and Ellen 'T hoen
by Patrice Trouiller, Piero Olliaro, Els Torreele, James Orbinski, Richard Laing, and Nathan Ford
333 7th Avenue, New York, NY 10001-5004
A 501(c)(3) tax-exempt organization. Federal Identification Number (EIN): 13-3433452.